Insulet Corp
Change company Symbol lookup
Select an option...
PODD Insulet Corp
CMSQF Computershare Ltd
BAC Bank of America Corp
UNH UnitedHealth Group Inc
RYAAY Ryanair Holdings PLC
FNGO MicroSectors? FANG+? Index 2X Leveraged ETN
VIVC Vivic Corp
LAD Lithia Motors Inc
SBUX Starbucks Corp
HYLN Hyliion Holdings Corp
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

Closing Price
$222.25
Day's Change
-6.47 (-2.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
230.12
Day's Low
221.33
Volume
(Heavy Day)
Volume:
441,006

10-day average volume:
294,599
441,006

Display:

Providers:

UpdateCancel
6 providers
October 29, 2020
Insulet Recognized as Global Impact Corporate Hero and Manufacturer of the Year

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced it is being honored by two Massachusetts agencies for...(BusinessWire)

October 20, 2020
Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced that Wayne A. I. Frederick, M.D., has been appointed...(BusinessWire)

October 05, 2020
Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced plans to release its financial results for the third quarter of 2020 on...(BusinessWire)

September 21, 2020
Insulet Expands its Offering of Omnipod DASH(R) Insulin Management System

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced it is commercially launching its Omnipod DASH(R)...(BusinessWire)

August 24, 2020
Injectable Drug Delivery Market Worth USD 1,251.28 Billion and 12.9% CAGR; Rising Cases of COVID-19 Pandemic to Promote Growth, says Fortune Business Insights(TM)

The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target...(Globe Newswire)

Insulet to Present at Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced that management will present at two virtual investor conferences: (BusinessWire)

August 06, 2020
Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced financial results for the three months ended June 30...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.